Breast Cancer Genome Guided Therapy Study (BEAUTY)

Request Access

Demographics (1)

  • Age.group - Patient age at date on study, marked in 10 year group (phv00258582.v1.p1)

Disease Events (17)

  • AFFECTION_STATUS - Case control status of the subject. All subjects are patients with Stage I-III breast cancer. (phv00258565.v1.p1)
  • Breast.Nodal.CR.all - Pathological complete response in breast and nodes (path-CR) after 24 weeks of chemo-therapy or the patient's regimen. (phv00258572.v1.p1)
  • Clinical.Molecular.Subtype - Clinical molecular tumor type, based on baseline Ki67 results, estrogen receptor level and HER2 status (by IHC or FISH) (phv00258573.v1.p1)
  • Estrogen.receptor - Estrogen Receptor level (phv00258578.v1.p1)
  • HER2.FISH - HER2 results by Fish (phv00258581.v1.p1)
  • HER2.IHC - HER2 results by IHC (phv00258580.v1.p1)
  • HISTOLOGIC_TYPE - Cell or tissue type or subtype of sample (phv00258587.v1.p1)
  • IS_TUMOR - Tumor status (phv00258586.v1.p1)
  • Ki67Sensitivity - Was tumor sensitive to chemo decreasing significantly by Ki67 measure? (phv00258577.v1.p1)
  • N.stage - Nodal stage, based on if tumor spread to lymph nodes by breast and, if so, how many nodes are affected (phv00258575.v1.p1)
  • Percentage.tumor.cells.baseline - Lab estimate of tumor percentage at baseline (phv00258576.v1.p1)
  • PRIMARY_TUMOR_LOCATION - Primary tumor location (phv00258589.v1.p1)
  • Progesterone.receptor - Progesterone Receptor level (phv00258579.v1.p1)
  • T.stage - Tumor stage, based on size and spread to skin or chest wall under breast (phv00258574.v1.p1)
  • TUMOR_GRADE - Tumor grade of sample (phv00258591.v1.p1)
  • TUMOR_STAGE - Tumor stage of sample (phv00258590.v1.p1)
  • TUMOR_TREATMENT - Type of tumor treatment for sample (phv00258592.v1.p1)

Other (15)